Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09LIZ
|
|||
| Former ID |
DIB001537
|
|||
| Drug Name |
KI-0502
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 3 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma. Eur J Cancer. 2015 Mar;51(4):522-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.